Total Payments
$13,360
2024 Payments
$1,286
Companies
59
Transactions
801
Medicare Patients
1,060
Medicare Billing
$105,197
Payment Breakdown by Category
Food & Beverage$12,574 (94.1%)
Other$426.15 (3.2%)
Education$359.83 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,574 | 772 | 94.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $426.15 | 23 | 3.2% |
| Education | $359.83 | 6 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,517 | 80 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,357 | 104 | $0 (2024) |
| Allergan, Inc. | $1,319 | 102 | $0 (2022) |
| Biogen, Inc. | $777.19 | 44 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $672.55 | 32 | $0 (2024) |
| Acorda Therapeutics, Inc | $566.66 | 28 | $0 (2024) |
| EMD Serono, Inc. | $562.70 | 32 | $0 (2024) |
| UCB, Inc. | $516.32 | 29 | $0 (2024) |
| SK Life Science, Inc. | $392.31 | 16 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $377.80 | 45 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,286 | 53 | ABBVIE INC. ($535.81) |
| 2023 | $1,541 | 83 | AbbVie Inc. ($490.70) |
| 2022 | $1,494 | 83 | Novartis Pharmaceuticals Corporation ($268.50) |
| 2021 | $1,660 | 101 | AbbVie Inc. ($250.38) |
| 2020 | $1,836 | 128 | Allergan, Inc. ($448.12) |
| 2019 | $2,050 | 128 | Allergan Inc. ($270.20) |
| 2018 | $1,693 | 99 | Allergan Inc. ($192.47) |
| 2017 | $1,800 | 126 | Biogen, Inc. ($331.67) |
All Payment Transactions
801 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.96 | General |
| Category: NEUROLOGY | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/24/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Rare Disease | ||||||
| 09/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: NEUROLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/28/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Neurology | ||||||
| 08/21/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/15/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Neurology | ||||||
| 08/14/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 08/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/11/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $32.44 | General |
| 07/03/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Immunology | ||||||
| 06/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: PAIN | ||||||
| 06/26/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Adenosine A2A Receptors | ||||||
| 06/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/06/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 269 | 366 | $88,655 | $26,513 |
| 2022 | 7 | 240 | 310 | $79,785 | $24,501 |
| 2021 | 6 | 265 | 348 | $81,880 | $26,972 |
| 2020 | 7 | 286 | 381 | $78,540 | $27,210 |
Total Patients
1,060
Total Services
1,405
Medicare Billing
$105,197
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 151 | $27,935 | $12,241 | 43.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 72 | 73 | $18,250 | $6,833 | 37.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 40 | $7,000 | $2,430 | 34.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 48 | 50 | $27,500 | $1,926 | 7.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 30 | $3,900 | $1,635 | 41.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 22 | $4,070 | $1,449 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 131 | $23,675 | $10,652 | 45.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 36 | 36 | $9,000 | $3,655 | 40.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 44 | 49 | $26,950 | $2,181 | 8.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,170 | $2,114 | 40.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $5,200 | $1,977 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 30 | $3,750 | $1,774 | 47.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 14 | 15 | $2,715 | $1,086 | 40.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 19 | $3,325 | $1,061 | 31.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 67 | 120 | $19,860 | $10,393 | 52.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 47 | 49 | $12,250 | $5,180 | 42.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 75 | $8,680 | $4,282 | 49.3% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 49 | 53 | $29,150 | $2,431 | 8.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 14 | $5,600 | $2,225 | 39.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 19 | 19 | $3,190 | $1,435 | 45.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 17 | 18 | $3,150 | $1,027 | 32.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 78 | 127 | $18,415 | $9,590 | 52.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 99 | $9,900 | $4,783 | 48.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 32 | 33 | $8,250 | $3,680 | 44.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 21 | 21 | $8,400 | $3,335 | 39.7% |
About Dr. Kent Berkey, M.D
Dr. Kent Berkey, M.D is a Neurology healthcare provider based in Washington, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396943742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kent Berkey, M.D has received a total of $13,360 in payments from pharmaceutical and medical device companies, with $1,286 received in 2024. These payments were reported across 801 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($12,574).
As a Medicare-enrolled provider, Berkey has provided services to 1,060 Medicare beneficiaries, totaling 1,405 services with total Medicare billing of $105,197. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Washington, PA
- Active Since 07/06/2007
- Last Updated 10/31/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1396943742
Products in Payments
- BOTOX (Biological) $1,418
- KESIMPTA (Drug) $636.89
- UBRELVY (Drug) $626.32
- INBRIJA (Drug) $442.65
- RYTARY (Drug) $436.73
- TYSABRI (Biological) $371.33
- TROKENDI XR (Drug) $349.79
- APTIOM (Drug) $323.29
- NURTEC ODT (Drug) $278.74
- AIMOVIG (Biological) $275.78
- NUPLAZID (Drug) $274.62
- QULIPTA (Drug) $261.56
- TECFIDERA (Drug) $235.87
- Rebif (Biological) $213.63
- Vimpat (Drug) $213.10
- APOKYN (Drug) $208.61
- AUBAGIO (Drug) $202.08
- GILENYA (Drug) $196.59
- BOTOX THERAPEUTIC (Biological) $189.57
- AJOVY (Biological) $186.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Washington
Dr. Laxman Bahroo, D.o,, D.O,
Neurology — Payments: $3.4M
Neurology $3.4M
Dr. Fahd Amjad, Md, MD
Neurology — Payments: $2.4M
Neurology $2.4M
Jessica Ailani, Md, MD
Neurology — Payments: $1.3M
Neurology $1.3M
Fernando Pagan
Neurology — Payments: $1.1M
Neurology $1.1M
Dr. Yasar Torres-Yaghi, M.d, M.D
Neurology — Payments: $868,293
Neurology $868,293
Benjamin Osborne
Neurology — Payments: $770,154
Neurology $770,154